Schroder NW, Schumann RP (2005). Single nucleotide polymorphism of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5(3):156-164.
Crossref

Mencin A, Kluwe J, Schwabe RF. (2009). Toll-Like receptors as targets in chronic liver disease. Gut 1:58(5):704-720.

He D, Tao S, Guo S, Li M, Wu J, Huang H, Guo X, Yan G, Zhu P, Wang Y (2015). Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese. Liver Int. 35:1941-1949
Crossref

Mish EA, Hawn TR. (2008). Toll-Like receptor polymorphisms and susceptibility to human disease. Clin. Sci. (L0nd) 1:114(5):347-360.

Bali P, Pradhan S, Sharma D, Adak T. (2013). Toll like receptor 2 and 4 polymorphisms in malaria endemic populations of India. Human Immunol. 74(2):223-229.
Crossref

Bart F, Matthew BB McCall, Karlijn Verheijen, Bart-Jan Kullberg, André JAM van der Ven, Jos WM Van der Meer, and Mihai G Netea . (2008). Functional Consequences of Toll-like Receptor 4 Polymorphisms. Mol. Med. 14(5-6):346-352.

Medvedev AE. (2013). Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer. J. Interferon. Cytokine Res. 1:33(9):467-84

Sadik NA, Shaker OG, Ghanem HZ, Hassan HA, and Abdel-Hamid AZ. (2015). Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients. Arch. Virol. 1:160(9):2181-2195.

Fernandez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E, Vargas V. (2007). Such J. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 1:133(3):818-824.

Jover M, Galan J, Hoyas E, del Campo JA, Montoliu C, del Olmo J, Baccaro E, Guevara M, Cordoba J, Navarro JM, Martinez-Sierra md.(2009). 754 positional cloning in gls gene: a microsatellite in the promoter region predicts the risk of hepatic encephalopathy. J. Hepatol. 1:50:s277.

Frances R, Zapater P, González‐Navajas JM, Mu-oz C, Ca-o R, Moreu R, Pascual S, Bellot P, Pérez‐Mateo M. (2008). Such J. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology 1:47(3):978-85.

Negro F (2014). Epidemiology of hepatitis C in Europe. Dig. Liver Dis. 46 suppl 5:S158-164.
Crossref

Testro AG, Gow P, Angus PW, Wongseelashote S, Skinner N, Markovska V, Visvanathan K (2010). Effect of antibiotics on expression and function of Toll-Like receptors 2 and 4 on mononuclear cells in patients with advanced cirrhosis. J. Hepatol. 1:52(2):199-205.

Yin X, Hou T, Liu Y. (2010). Association of Toll-Like receptor 4 gene polymorphism and expression with urinary tract infection types in adults. Plos One 5 (12),3:e14223.

Tazi KA, Quioc JJ, Saada V, Bezeaud A, Lebrec D, Moreau R.(2006). Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of AKT and IRAK-M. J. Hepatol, 45:280-289.
Crossref

Stadlbauer V, Mookerjee RP, Hodges S, Wright GA, Davies NA, Jalan R. (2008). Effect of probiotic treatment on deranged neutrophil function and cytokine response in patients with compensated alcoholic cirrhosis. J. Hepatol. 48:945-951.
Crossref

Zhang K, Zhou B, Wang Y, Rao L, Zhang L. (2013). The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis. Eur. J. Cancer. 49:946-954.
Crossref

Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, Hamilton JA, Bengmark S, Williams R, Visvanathan K. (2003). Peripheral blood mononuclear cell expression of Toll-Like receptors and relation to cytokine levels in cirrhosis. Hepatology 37:1154.-1164.

Manigold T, Böcker U, Hanck C, Gundt J, Traber P, Antoni C, Rossol S. (2003). Differential expression of Toll-Like receptors 2 and 4 in patients with liver cirrhosis. Eur. J. Gastroenterol. Hepatol. 15:275-282.
Crossref